QT
RVMD icon

Quantamental Technologies’s Revolution Medicines RVMD Stock Holding History

Quantamental Technologies’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,392
Closed -$224K – 594
2022
Q4 		$224K Buy
+9,392
New +$200K 0.1% 336

Other funds holding RVMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Quantamental Technologies's RVMD Position: Q1 2023 in Review

Quantamental Technologies sold out of Revolution Medicines (RVMD) in Q1 2023, closing a stake of 9,392 shares — an estimated $224K sold.

Quantamental Technologies first reported a position in RVMD in Q4 2022 and held it in 1 quarter. The position peaked at $224K in Q4 2022. 152 funds tracked by Wall St. Rank hold RVMD as of Q1 2023.

  • Quantamental Technologies reported no remaining Revolution Medicines position as of Q1 2023 after selling out during the quarter.
  • Quantamental Technologies sold 9,392 Revolution Medicines shares in Q1 2023, an estimated $224K.
  • Quantamental Technologies first reported a position in Revolution Medicines in Q4 2022 and held it in 1 quarter.
  • Quantamental Technologies's Revolution Medicines position peaked at $224K in Q4 2022.
  • 152 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2023.

Based on Quantamental Technologies's 13F filing for Q1 2023, filed 15 May 2023.